Last updated: February 25, 2026
What is the scope of AU2005240131?
Patent AU2005240131 is a pharmaceutical patent granted in Australia. It primarily covers inventions related to a specific formulation, method of manufacture, or therapeutic use involving a pharmaceutical compound or combination. The patent aims to protect a drug candidate or a treatment approach with specific structural, formulation, or process features.
The scope is delineated by the claims, which precisely define the legal boundaries of the patent. The patent's description elaborates on the invention’s technical details, but it is the claims that determine enforcement and infringement.
Key Attributes of the Scope:
- Exploits a novel compound, formulation, or therapeutic method.
- May include specific chemical structures or derivatives.
- Could cover specific dosage forms or delivery mechanisms.
- Likely includes process claims for manufacturing.
Without access to the exact claims text, a typical scope for a pharmaceutical patent in this field might encompass a novel compound class, its salts or derivatives, and pharmaceutical compositions or methods for treating particular conditions.
What are the primary claims of AU2005240131?
While the full claims are not provided here, pharmaceutical patents in Australia generally include:
- Compound Claims: Covering the molecular structure or derivatives.
- Use Claims: Methods for using the compound to treat or prevent specific diseases.
- Formulation Claims: Pharmaceutical compositions containing the compound.
- Method of Manufacturing: The process steps to produce the compound or formulation.
A typical claim structure might be:
"A pharmaceutical composition comprising [compound or derivative] substantially as described."
"A method of treating [disease] in a subject, comprising administering an effective amount of [compound]."
Claims are typically broad at the outset, narrowing in dependent claims that specify additional features or limitations.
What does the patent landscape for Australia look like for this type of patent?
Major Competitor and Patent Clusters
The Australian pharmaceutical patent landscape is competitive, with notable activity from:
- Major multinational pharmaceutical companies.
- Biotechnology firms focusing on novel compounds.
- Universities and research institutions filing early-stage patents.
Patent families related to the compound, or its therapeutic use, are filed globally, including in the US, Europe, and Asia, forming a ready patent landscape.
Patent Family and Related Applications
- The earliest priority date for AU2005240131 is likely linked to an international application under PCT or direct filing.
- The patent is part of a broader family aiming to secure protection across major markets.
- Related patents may cover salts, polymorphs, or specific formulations.
Patent expirations and lifecycle
- Australian patents last 20 years from the filing date, typically around 2025-2026 for filings made in 2005.
- If maintenance fees are paid, patent rights remain enforceable until expiration.
- The patent's lifespan influences commercialization strategies and potential for generic entry.
Patentability and Patent Challenges
In Australia, patentability hinges on novelty, inventive step, and utility, with key considerations including:
- Whether the compound or process was disclosed publicly before.
- Whether it involves an inventive step beyond the current knowledge.
- Demonstration of proper utility.
Patent invalidation cases in Australia often involve prior art artifactual disclosures or obviousness arguments.
Recent Trends and Legal Environment
- Australia adopted a patent term extension for pharmaceuticals in line with international standards.
- The Patent Office has increased scrutiny on patent claims that lack inventive step or are merely modifications of known compounds.
- Patent oppositions are less common but more strategic in the pre-grant phase.
Comparison with Global Patent Landscape
Compared to US and European jurisdictions:
- Australia's patent system is more stringent on obviousness.
- It emphasizes utility and soundness more strictly.
- Patent term extensions are less common unless specifically legislated.
Summary of Strategic Considerations
- The patent’s scope determines market exclusivity; overly broad claims risk invalidation.
- Narrow claims may facilitate licensing or partnership but limit enforceability.
- Patent landscape analysis highlights key competitors and potential patent overlap.
- Patent expiry timelines influence R&D pipeline planning.
- Past litigation and opposition history inform patent strength assessments.
Key Takeaways
- The scope of AU2005240131 likely covers a specific compound or use, with claims focusing on therapeutic applications.
- The patent landscape involves global patent families, with targeted geographic protection.
- Australia’s patent systems favor precise claims, with increasing scrutiny on obviousness and utility.
- Patent expiry around 2025-2026 marks a critical horizon for market strategies.
- Competitor patent filings and prior art searches are essential to evaluate freedom-to-operate.
FAQs
1. What are the typical claim types in pharmaceutical patents like AU2005240131?
Compound claims, use claims, formulation claims, and process claims.
2. How does Australian patent law affect pharmaceutical patent scope?
It emphasizes novelty, inventive step, and utility, with stricter standards on obviousness compared to some jurisdictions.
3. When does the patent AU2005240131 expire?
Assuming the filing date was around 2005, the patent would expire in 2025 unless extended or maintained through renewal fees.
4. How does patent landscape analysis inform licensing strategies?
It reveals overlapping patents and potential freedom to operate, guiding licensing or sublicense agreements.
5. What are common challenges to patent validity in Australia?
Prior art disclosures, obvious modifications, or lack of demonstrated utility can lead to invalidation.
References
[1] Australian Patent Office. (2022). Guidelines for Patent Examination. Retrieved from https://www.ipaustralia.gov.au/patents
[2] World Intellectual Property Organization. (2023). Patent Laws and Regulations. Retrieved from https://www.wipo.int
[3] European Patent Office. (2022). Patent search and analysis. Retrieved from https://www.epo.org/
[4] Australian Patent Office. (2018). Pharmaceutical Patent Guidelines. Retrieved from https://www.ipaustralia.gov.au/patents
